{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:19:28Z","timestamp":1790266768262,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R13CA159788-01"],"award-info":[{"award-number":["1R13CA159788-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL069254"],"award-info":[{"award-number":["U01HL069254"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA078938"],"award-info":[{"award-number":["R01 CA078938"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54AI082973"],"award-info":[{"award-number":["U54AI082973"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R13AI094943"],"award-info":[{"award-number":["R13AI094943"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"crossref","award":["360529"],"award-info":[{"award-number":["360529"]}],"id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.bbmt.2016.12.619","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T21:34:14Z","timestamp":1483738454000},"page":"379-387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT"],"prefix":"10.1016","volume":"23","author":[{"given":"Jennifer","family":"Heimall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Puck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Fleisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Gennery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Slatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Scott","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-8420","authenticated-orcid":false,"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1088-8045","authenticated-orcid":false,"given":"Mort J.","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.12.619_bib0010","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaci.2007.08.007","article-title":"Long-term immune reconstitution and clinical outcome post stem cell transplantation for SCID","volume":"120","author":"Mazzolari","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0015","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jpeds.2009.07.049","article-title":"Long-term clinical outcome of patients with SCID who received related donor bone marrow transplants without pre-transplants chemotherapy or post-transplant GVHD prophylaxis","volume":"155","author":"Railey","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0020","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1182\/blood-2008-09-177923","article-title":"Long-term outcome after hematopoietic stem cell transplantation of a single center cohort of 90 patients with severe combined immunodeficiency","volume":"113","author":"Neven","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaci.2010.06.015","article-title":"Transplantation of HSC and long-term survival for immunodeficiencies in Europe: entering a new century, do we do better?","volume":"126","author":"Gennery","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12026-010-8191-9","article-title":"Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes","volume":"49","author":"Buckley","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0035","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"NEJM"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0040","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.2014.9132","article-title":"Newborn screening for combined immunodeficiency in 11 programs in the United States","volume":"312","author":"Kwan","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0045","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.semperi.2015.03.004","article-title":"History and current status of newborn screening for severe combined immunodeficiency","volume":"39","author":"Kwan","year":"2015","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0050","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.bbmt.2016.05.024","article-title":"Late effects post umbilical cord blood transplant in very young children after busulfan based, myeloablative conditioning","volume":"22","author":"Allewelt","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley","year":"1999","journal-title":"NEJM"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0060","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V99.3.872","article-title":"Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival","volume":"99","author":"Myers","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0065","first-page":"3646","article-title":"Long-term immune reconstitution and outcome after HLA-Nonidentical T cell depleted bone marrow transplantation for SCID: a European retrospective study of 116 patients","volume":"91","author":"Haddad","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","article-title":"Long-term survival and transplantation of haematopoietic stem cells for immunodeficiencies: report of the European experience 1968-1999","volume":"361","author":"Antoine","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0075","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1182\/blood-2010-08-300384","article-title":"Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screening","volume":"117","author":"Brown","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0080","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jaci.2014.02.042","article-title":"Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency","volume":"133","author":"Hassan","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0085","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jama.295.5.508","article-title":"Bone marrow transplantation for severe combined immune deficiency","volume":"295","author":"Grunebaum","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0090","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jaci.2013.01.047","article-title":"B cell reconstitution for SCID: Should a conditioning regimen be used in SCID treatment?","volume":"131","author":"Haddad","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0095","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of HSCT for ADA-deficient SCID","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0100","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/bmt.2013.6","article-title":"Long-term outcome of non-ablative booster bone marrow transplantation in patients with SCID","volume":"48","author":"Teigland","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0105","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jaci.2014.06.021","article-title":"Comparison of outcomes of HSCT without chemotherapy conditioning using matched sibling and unrelated donors for treatment of SCID","volume":"134","author":"Dvorack","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0110","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/blood-2011-06-363572","article-title":"Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?","volume":"119","author":"Fernandes","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0115","doi-asserted-by":"crossref","first-page":"4575-4581","DOI":"10.1182\/blood-2006-07-029090","article-title":"Long-term T-cell reconstitution after hematopoietic stem-cell transplantation in primary T-cell-immunodeficient patients is associated with myeloid chimerism and possibly the primary disease phenotype","volume":"109","author":"Cavazzana-Calvo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0120","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1016\/S0022-3476(99)70291-X","article-title":"Influence of SCID phenotype on the outcome of HLA non-identical, T cell depleted bone marrow transplantation: a retrospective European survey from the European Group for Bone Marrow Transplantation and the European Society for Immunodeficiency","volume":"134","author":"Bertrand","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/146532401753174052","article-title":"CAMPATH-1M T cell depleted BMT for SCID: long-term follow up of 119 children treated 1987-98 in a single center","volume":"3","author":"Gennery","year":"2001","journal-title":"Cytotherapy"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2004-03-0960","article-title":"Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced- intensity conditioning regimen","volume":"105","author":"Rao","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1399-3046.2011.01529.x","article-title":"Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipients","volume":"15","author":"Malar","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0140","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/sj.bmt.1702382","article-title":"Dental manifestations in severe combined immunodeficiency following bone marrow transplantation","volume":"25","author":"Cole","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0145","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.bmt.1704456","article-title":"Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning","volume":"33","author":"Slatter","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2013-01-476432","article-title":"SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS deficient SCID","volume":"123","author":"Schuetz","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0155","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bjh.13497","article-title":"Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan","volume":"170","author":"Panasiuk","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0160","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/bmt.2015.171","article-title":"Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases","volume":"50","author":"Slatter","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0165","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","article-title":"Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience","volume":"117","author":"Slatter","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FTD.0000000000000131","article-title":"Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use","volume":"37","author":"Long-Boyle","year":"2015","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0175","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.bbmt.2013.08.014","article-title":"Effect of weight and maturation on busulfan clearance in infants and small children undergoing hematopoietic cell transplantation","volume":"19","author":"Savic","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0180","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2015.04.027","article-title":"Radiation sensitive SCID: the arguments for and against conditioning before HSCT- What to Do?","volume":"136","author":"Cowan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0185","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.bmt.1702831","article-title":"Bone marrow transplant for T-B- SCID in Athabascan-speaking native Americans","volume":"27","author":"O'Marcaigh","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0190","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-012-9797-6","article-title":"Post-transplantation B cell function in different molecular forms of SCID","volume":"33","author":"Buckley","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0195","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bbmt.2011.11.014","article-title":"NCI, NHLBI\/PBMTC first international conference on late effects after pediatric HSCT: persistent immune deficiency in pediatric transplant survivors","volume":"18","author":"Bunin","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10875-006-9058-7","article-title":"The effect of natural killer (NK) KIR alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID)","volume":"27","author":"Keller","year":"2007","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0205","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/ni.3553","article-title":"Evidence of innate lymphoid cell redundancy in humans","volume":"17","author":"V\u00e9ly","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0210","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1182\/blood-2006-01-009241","article-title":"Early determinants of long-term T cell reconstitution after HSCT for SCID","volume":"108","author":"Borghans","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0215","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1182\/blood.V96.13.4344","article-title":"Similar pattern of thymic-dependent T-cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation","volume":"96","author":"Mueller","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0220","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bmt.2012.186","article-title":"Haploidentical related donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34 (+) cells and a fixed CD3 (+) dose","volume":"48","author":"Dvorak","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0225","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.4049\/jimmunol.136.7.2398","article-title":"Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation","volume":"136","author":"Buckley","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0230","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood.V74.6.2212.2212","article-title":"Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency","volume":"74","author":"Wijnaendts","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0235","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM200005043421804","article-title":"Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"342","author":"Patel","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0240","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1182\/blood-2009-01-199323","article-title":"Thymic output, T cell diversity and T cell function in long-term human SCID chimeras","volume":"114","author":"Sarzotti-Kelsoe","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12026-010-8192-8","article-title":"The long and the short of telomeres in bone marrow recipient SCID patients","volume":"49","author":"Sarzotti-Kelsoe","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0250","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.V81.8.2021.2021","article-title":"Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation","volume":"81","author":"Dror","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng.278","article-title":"Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness","volume":"41","author":"Lagresle-Peyrou","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0260","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2008-04-151332","article-title":"Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies","volume":"112","author":"Titman","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0265","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2003.10.055","article-title":"Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency","volume":"144","author":"Albuquerque","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0270","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0387-7604(96)00014-9","article-title":"Sensorineural deafness in siblings with adenosine deaminase deficiency","volume":"18","author":"Tanaka","year":"1996","journal-title":"Brain Dev"},{"key":"10.1016\/j.bbmt.2016.12.619_bib0275","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaci.2011.10.028","article-title":"Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency","volume":"129","author":"Kesserwan","year":"2012","journal-title":"J Allergy Clin Immunol"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116311764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:23Z","timestamp":1761058643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116311764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1083879116311764"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.619","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.12.619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}